GOAL Trial Shows Penicillin Significantly Reduces the Progression of Latent RHD in Ugandan Children

18 Nov 2021
18 Nov 2021

Findings of a clinical trial published in the New England Journal of Medicine on 13 November 2021 shed new light on the efficacy of secondary antibiotic prophylactic penicillin in preventing the progression of latent rheumatic heart disease in children and adolescents. Authors found that patients who received prophylactic penicillin were significantly less likely to experience disease progression compared to those who did not receive treatment - an important finding for future treatment recommendations and further research.

Take a look at these press releases and blog posts to find out more about the trial and next steps:

 Murdoch Children's Research Institute

 Cincinnati Children's

Cincinnati Children's - Research Horizons Blog

Children's National Hospital